Glenmark Pharmaceuticals informs about media release

27 May 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 27th May 2020 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Chlorzoxazone Tablets USP, 375 mg and 750 mg; Glenmark’s first ANDA approval out of their new US facility’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1954.70 7.10 (0.36%)
18-Dec-2025 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.00
Dr. Reddys Lab 1277.80
Cipla 1504.70
Zydus Lifesciences 915.85
Lupin 2121.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×